Skip to main content
. 2016 Jul 21;11(10):1845–1855. doi: 10.2215/CJN.00190116

Figure 2.

Figure 2.

The association between mammalian target of rapamycin inhibitor (mTORi) use and all–cause and cause–specific death in kidney transplant recipients. Analyses using mTORi use at baseline and 1 year are restricted to the first allograft. 95% CI, 95% confidence interval; HR, hazard ratio; LOCF, last observation carried forward; TVC, time-varying covariate.